Quipt Home Medical Announces Up-listing to the Toronto Stock Exchange Cincinnati, Ohio

Quipt Home Medical Announces Up-listing to the

Toronto Stock Exchange

Cincinnati, Ohio - June 20, 2023 -

Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home

medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has received final approval to

list its common shares on the Toronto Stock Exchange (the "TSX") and will commence trading on the TSX at market open

on June 21, 2023 under the symbol "QIPT". Concurrent with the commencement of trading on the TSX, the common shares will

be delisted and will cease trading on the TSX Venture Exchange.

"We are incredibly proud to announce the

commencement of trading on the Toronto Stock Exchange. This significant milestone underscores our commitment to growth and provides a

strong foundation for our investors. As we work to establish ourselves as a national leader in respiratory care across the United States,

our ability to list on the TSX shows the sustained expansion of our organization over the years and the ongoing momentum across the business,"

said Greg Crawford, Chairman and CEO of Quipt. "We believe that this listing will provide us with increased visibility and access

to a broader investor base, which will further support our mission to deliver exceptional value to our shareholders. We're excited

about this next step in our journey and are deeply appreciative of the support from our investors, our team, and the TSX."

Shareholders are not required to exchange their

share certificates or take any other action in connection with the TSX listing. There will be no change in the trading symbol or CUSIP

for the common shares. In addition, the Company's common shares will continue to trade on NASDAQ in the United States under the

ABOUT QUIPT HOME MEDICAL CORP.

The Company provides in-home monitoring and disease

management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue

to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease,

sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder

value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company's

organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the

patient's services, and making life easier for the patient.

Certain statements contained in this press

release constitute "forward-looking information" as such term is defined in applicable Canadian securities

legislation. The words "may", "would", "could", "should", "potential", "will",

"seek", "intend", "plan", "anticipate", "believe", "estimate", "expect",

"outlook", and similar expressions as they relate to the Company, including: the Company establishing itself

as a national leader in respiratory care across the United States; and the Company believing that its TSX listing will provide it with

increased visibility and access to a broader investor base ; are intended to identify forward-looking information. All statements

other than statements of historical fact may be forward- looking information. Such statements reflect the Company's

current views and intentions with respect to future events, and current information available to the Company, and

are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance

or achievements that may be expressed or implied by such forward-looking information to vary from those described

herein should one or more of these risks or uncertainties materialize. Examples of such risk factors include, without

limitation: risks related to credit, market (including equity, commodity, foreign exchange and interest rate), liquidity,

operational (including technology and infrastructure), reputational, insurance, strategic, regulatory, legal, environmental,

and capital adequacy; the general business and economic conditions in the regions in which the Company operates; the

ability of the Company to execute on key priorities, including the successful completion of acquisitions, business

retention, and strategic plans and to attract, develop and retain key executives; difficulty integrating newly acquired

businesses; the ability to implement business strategies and pursue business opportunities; low profit market segments;

disruptions in or attacks (including cyber-attacks) on the Company's information technology, internet, network access

or other voice or data communications systems or services; the evolution of various types of fraud or other criminal

behavior to which the Company is exposed; the failure of third parties to comply with their obligations to the Company

or its affiliates; the impact of new and changes to, or application of, current laws and regulations; decline of reimbursement

rates; dependence on few payors; possible new drug discoveries; a novel business model; dependence on key suppliers;

granting of permits and licenses in a highly regulated business; the overall difficult litigation environment, including

in the U.S.; increased competition; changes in foreign currency rates; increased funding costs and market volatility

due to market illiquidity and competition for funding; the availability of funds and resources to pursue operations;

critical accounting estimates and changes to accounting standards, policies, and methods used by the Company; the

occurrence of natural and unnatural catastrophic events and claims resulting from such events; and risks related to

COVID-19 including various recommendations, orders and measures of governmental authorities to try to limit the pandemic,

including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place

and social distancing, disruptions to markets, economic activity, financing, supply chains and sales channels, and

a deterioration of general economic conditions including a possible national or global recession; as well as those

risk factors discussed or referred to in the Company's disclosure documents filed with United States Securities

and Exchange Commission and available at www.sec.gov, and with the securities regulatory authorities in certain provinces

of Canada and available at www.sedar.com. Should any factor affect the Company in an unexpected manner, or should

assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially

from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety

by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness

of such forward-looking information. The forward-looking information included in this press release is made as of

the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking

information, other than as required by applicable law .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange)

accepts responsibility for the adequacy or accuracy of this release.

further information please visit our website at www.Quipthomemedical.com, or contact:

VP of Corporate Development

Quipt Home Medical Corp.

Chief Executive Officer

Quipt Home Medical Corp.